ICPO Forum 2025: advancing theranostics in precision oncology
- PMID: 40599741
- PMCID: PMC12212103
- DOI: 10.1016/j.lanepe.2025.101357
ICPO Forum 2025: advancing theranostics in precision oncology
Conflict of interest statement
Richard Paul Baum is an advisor to 3B Pharmaceuticals, ITM, Novartis, Swiss Rockets, and Telix Pharmaceuticals. He is founder/co-founder of RadioVaxx, NucleoGenesis, and ZENTA. He is member of the ICPO Board of Trustees, and President of the ICPO Academy (no payment). Odile Jaume has no competing interest to declare.
Similar articles
-
The ICPO Foundation-on the way toward collaborative growth of theranostics.Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):443-444. doi: 10.1007/s00259-021-05651-2. Eur J Nucl Med Mol Imaging. 2022. PMID: 34984500 Free PMC article. No abstract available.
-
Role of cis-acting sequences of the ICPO promoter of herpes simplex virus type 1 in viral pathogenesis, latency and reactivation.J Gen Virol. 1996 Aug;77 ( Pt 8):1853-63. doi: 10.1099/0022-1317-77-8-1853. J Gen Virol. 1996. PMID: 8760437
-
Empowering Exosomes with Aptamers for Precision Theranostics.Small Methods. 2025 Jun;9(6):e2400551. doi: 10.1002/smtd.202400551. Epub 2024 Jul 5. Small Methods. 2025. PMID: 38967170 Review.
-
Harnessing Photo-Energy Conversion in Nanomaterials for Precision Theranostics.Adv Mater. 2025 May 16:e2501623. doi: 10.1002/adma.202501623. Online ahead of print. Adv Mater. 2025. PMID: 40376855 Review.
-
Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.Radiographics. 2020 Oct;40(6):1715-1740. doi: 10.1148/rg.2020200021. Radiographics. 2020. PMID: 33001789 Review.
References
-
- Pomykala K.L., Hadaschik B.A., Sartor O., et al. Next generation radiotheranostics promoting precision medicine. Ann Oncol. 2023;34(6):507–519. https://www.annalsofoncology.org/article/S0923-7534(23)00113-8/fulltext - PubMed
-
- Abdel-Wahab M., Giammarile F., Carrara M., et al. Radiotherapy and theranostics: a lancet oncology commission. Lancet Oncol. 2024;25:e545–e580. www.thelancet.com/commissions-do/radiotherapy-theranostics - PubMed
-
- Benefits & expectations of an ICPO accredited theranostics center. www.icpo.foundation/icpo-centers/benefits-expectations/
-
- ICPO Academy for theranostics. www.theranostics.academy
LinkOut - more resources
Full Text Sources